Partnering with healthcare systems to improve HPV vaccination:The perspective of immunization program managers.
human papillomavirus vaccine
immunization manager
quality improvement
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 12 2021
02 12 2021
Historique:
pubmed:
30
10
2021
medline:
19
4
2022
entrez:
29
10
2021
Statut:
ppublish
Résumé
The US's 64 CDC-funded immunization programs are at the forefront of efforts to improve the quality of adolescent vaccination services. We sought to understand immunization program managers' perspectives on partnering with healthcare systems to improve HPV vaccine uptake. Managers of 44 state and local immunization programs completed our online survey in 2019. Immunization managers strongly endorsed the importance of partnering with systems to improve HPV vaccine uptake (mean = 3.8/4.0), and most wanted to do so in the next year (mean = 3.5). Immunization managers reported that common barriers included difficulty contacting systems' leadership (57%), differing organizational cultures (52%), and time (52%). Many perceived systems as not prioritizing HPV vaccination (77%). Immunization managers expressed strong interest in participating in a training on partnering with systems (mean = 3.5). Overall, immunization managers are highly interested in partnering with systems to improve HPV vaccine uptake. Training and other support are needed to expand programs' capacity for such partnerships. PLAIN LANGUAGE SUMMARYImmunization managers are interested in partnering with healthcare systems to improve HPV vaccination. However, support may be needed to facilitate partnerships between immunization programs and healthcare systems.
Autres résumés
Type: plain-language-summary
(eng)
PLAIN LANGUAGE SUMMARYImmunization managers are interested in partnering with healthcare systems to improve HPV vaccination. However, support may be needed to facilitate partnerships between immunization programs and healthcare systems.
Identifiants
pubmed: 34715005
doi: 10.1080/21645515.2021.1993041
pmc: PMC8903958
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
5402-5406Subventions
Organisme : NCI NIH HHS
ID : T32 CA057726
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001073
Pays : United States
Organisme : ACL HHS
ID : U01IP001073
Pays : United States
Références
Hum Vaccin Immunother. 2021 Oct 3;17(10):3577-3586
pubmed: 34152924
Pediatrics. 2014 Aug;134(2):e346-53
pubmed: 25002671
Prev Med Rep. 2016 May 16;4:94-7
pubmed: 27413667
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116
pubmed: 32817598
Hum Vaccin Immunother. 2020 Aug 2;16(8):1884-1887
pubmed: 32017649
Health Aff (Millwood). 2016 Sep 1;35(9):1638-42
pubmed: 27605644
Pediatrics. 2016 Jun;137(6):
pubmed: 27244856
Transl Behav Med. 2019 Jan 1;9(1):23-31
pubmed: 29471460
J Community Health. 2019 Aug;44(4):790-795
pubmed: 31102115
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):724-728
pubmed: 31437140
Health Aff (Millwood). 2020 Aug;39(8):1321-1325
pubmed: 32744941
Acad Pediatr. 2021 May-Jun;21(4S):S40-S47
pubmed: 33958091
Transl Behav Med. 2022 Jan 18;12(1):
pubmed: 34244807
Prev Chronic Dis. 2019 Jul 03;16:E85
pubmed: 31274411